Visannette
Visannette is a medicine authorised by Swissmedic under authorisation number 67184. The authorisation holder is Berlis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 November 2018 and the authorisation is valid without a time limit. ATC code G03DB08 places the medicine in the group Sex hormones and modulators of the genital system.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Visannette, Tabletten | B | 12 November 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 x 14 | Tablette(n) | G03DB08 | 09.99.0. | B |
| 2 | 6 x 14 | Tablette(n) | G03DB08 | 09.99.0. | B |
| 3 | 12 x 14 | Tablette(n) | G03DB08 | 09.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Visannette authorised in Switzerland?
Yes. Visannette is authorised by Swissmedic under authorisation number 67184, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Visannette have?
Visannette is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Visannette?
The authorisation holder is Berlis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.